Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ESCITALOPRAM OXALATE

ESCITALOPRAM OXALATE

Standard Dose
20MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview ESCITALOPRAM OXALATE is listed in Drugs@FDA under application 078467 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient ESCITALOPRAM OXALATE Form and strength TABLET; ORAL - 20MG Sponsor SANDOZ Submission history Latest submission status date: 2007-10-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview ESCITALOPRAM OXALATE is listed in Drugs@FDA under application 078467 (ANDA). Marketing status: None (Tentative Approval) Active ingredient ESCITALOPRAM OXALATE Form and strength TABLET; ORAL - 20MG Sponsor SANDOZ Submission history Latest submission status date: 2007-10-18 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.
ESCITALOPRAM OXALATE (ESCITALOPRAM OXALATE) | Drug Monograph | MedicHelpline